Lawyer rankings

Nathaniel Asker

Work Department

Antitrust and Competition

Position

Mr. Asker is an antitrust and competition partner. His practice focuses on antitrust aspects of mergers, acquisitions, and joint ventures and represents clients before the US Department of Justice and Federal Trade Commission. He has advised clients in a range of industries, including technology and software, aerospace and defense, consumer products, pharmaceuticals, manufacturing, energy, and financial services, among others.

Member

Mr. Asker currently serves on the Antitrust and Trade Regulation Committee of the Association of the Bar of the City of New York and is a member of the Antitrust Sections of the American Bar Association and the New York State Bar Association. He is also on the Editorial Board of The Antitrust Source, the online journal of the ABA Antitrust Section, and is a fellow of the American Bar Foundation.

Education

Mr. Asker received his JD from the University of Pennsylvania, cum laude, in 2005 and his BA from the University of Virginia, distinguished major, in 2000.

United States: Antitrust

Merger control

At Fried, Frank, Harris, Shriver & Jacobson LLP, New York-based partner Nathaniel Asker is the main contact in the US, following former global chair Bernard Nigro‚Äôs appointment as deputy assistant attorney general at the DOJ. Tobias Caspary, who divides time between London and Frankfurt, is the key EU partner. Asker works closely with Caspary on all antitrust aspects of US and cross-border transactions. In 2017, highlights included acting as antitrust counsel to Coach in its $2.4bn acquisition of Kate Spade & Company, and advising Knight Transportation on its merger with Swift Transportation. Associate Aleksandr Livshits in New York is highly regarded.

Search News and Articles

AVELLUM acted as the Ukrainian legal counsel to the Ministry of Finance of Ukraine in connection with two syndicated EUR-denominated facilities arranged by Deutsche Bank in December 2018 and March 2019 for the total amount equivalent to approximately USD1 billion.

AVELLUM acted as the Ukrainian legal counsel to the European Bank for Reconstruction and Development (‚ÄúEBRD ‚ÄĚ) and the Black Sea Trade and Development Bank (" BSTDB ") in connection with senior secured loans in the total amount of up to EUR36.3 million to Rengy Bioenergo LLC (‚ÄúLoans ‚ÄĚ).

The document entitled "Statement of Changes to Immigration Rules" which was released by the House of Commons on the 7th March 2019, outlined and advised us on a number of changes that will come into place that will affect the Tier 1 Investor Visa amongst other visa programmes and schemes. The latest article on our website discusses both of these new UK business visa routes. Our immigration lawyers London are already up to date on all of the required information for both the NEW Tier 1 Start-Up Visa and the NEW Tier 1 Innovator Visa .

According to the new document from the House of Commons on March 7th 2019 titled ‚ÄúStatement of Changes to Immigration Rules‚ÄĚ, a number of changes will come into place that affecting the Tier 1 UK Investor Visa programme amongst other visa programmes and schemes. Read about them in our latest¬† article .¬†

There is no doubt that the UK has to date benefited immensely from visa-free EU¬†immigration to the extent that visa conditions and caps on non-EU migrant have undermined and overshadowed the ability of this group to play a prominent role in British industry and commerce and in its expanding and overburdened NHS service. It is the view of¬† Gulbenkian Andonian ¬†however, that after¬† Brexit, there should be a noticeable change in those skilled non-EU migrants contributing to British society in a meaningful way.¬†

From 1 January 2021 everyone except for British and Irish citizens will be subject to immigration control in the UK. ¬† Gulbenkian Andonian solicitors has already published an article on this topic of post- Brexit immigration and has discussed the case of EU nationals and family members after Brexit, you can find that article here as one of many in our blog .

A medical practice cannot advertise using the term ‚ÄúPraxisklinik‚ÄĚ (‚Äúclinic‚ÄĚ in English) if it does not provide overnight accommodation. That was the view upheld by the Bundesgerichtshof (BGH) in a ruling from October 17, 2018 (Az.: I ZR 58/18).